HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies. While trastuzumab deruxtecan has shown superior activity ...
Study to be conducted by PharmaLegacy, a leading Contract Research Organization The scientific rationale for evaluating ...
Cancer nanotechnology stands at the forefront of nanobiotechnology, drawing together innovation from materials science, engineering, and the biomedical ...
The field of pathology is rapidly evolving toward the integration of molecular and cellular levels, immunology, and digital advances to better understand ...
In a first-in-human study, researchers at The University of Texas MD Anderson Cancer Center observed strong responses and early signs of antitumor activity in patients with difficult-to-treat ...
In research that could shed light on the growth and formation of complex tissue architectures, Brown University engineers show how cells orbit and reconfigure their surroundings to venture outward ...
Renal cell carcinoma (RCC) arises in a highly complex tumor microenvironment (TME), where malignant epithelial cells often make up only a minority of the cancer tissue. Traditional bulk sequencing ...
BOSTON — Scientists at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with the Multiple Myeloma Research Foundation (MMRF) and leading institutions across the country, have contributed ...
The tumor microenvironment (TME) consists of mediators surrounding a tumor, including diverse cell types, blood vessels, and other cellular components. Certain elements of the TME can benefit patients ...
Abstract: The investigation of the cellular microenvironment is of great interest, as many physiological processes can be disrupted by the onset of diseases. Many biomarkers play a crucial role in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results